Yaz News | Yaz Side Effects 2013

A Yaz side effect lawsuit was filed in the Superior Court of the State of California, San Francisco, on March 19, 2013.

The plaintiffs include five women who claim to have suffered from DVT (Deep Vein Thrombosis), and other injuries arising from the use of Yaz.

According to court documents, the women contest that Bayer HealthCare Pharmaceuticals – the manufacturer of Yaz, should have known its Yaz birth control product could cause DVT, and that it was a high-risk drug.

Warning from the FDA (Food and Drug Administration):

WARNINGS AND PRECAUTIONS

Thromboembolic Disorders and Other Vascular Problems

Based on presently available information on Yasmin, DRSP-containing COCs may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing the progestin levonorgestrel or some other progestins…

Women taking or who have taken birth control pills that contain Drospirenone have a sevenfold risk of developing blood clots compared to women who take birth control pills that contain levonorgestrel (a synthetic progestogen).

On April 11 2012, the FDA ordered Bayer to provide stronger and more clear warnings on their packaging labels of Yaz and Yasmin blood-clot dangers.

Today, there are more than 13,000 pending Yaz lawsuits, yet Yaz, Yasmin and Ocella remain some of Bayer’s highest-selling pharmaceuticals.

Anyone affected by pulmonary embolism, blood clots, DVT or stroke after taking Yaz, Yasmin, BeYaz, or Ocella should contact a Multi-district Litigation Lawyer (MDL) who handles Yaz cases.

To contact a MDL attorney that represents women who have been harmed by Yaz, Yasmin, BeYaz or Ocella either fill out the form to your right, or visit our site at The Maher Law Firm

Yaz Warning Letter

In a warning letter from the Department Of Health & Human Services

“The Division of Drug Marketing, Advertising, and Communications (DDMAC) has reviewed two 60-second direct-to-consumer (DTC) broadcast television advertisements (TV Ads) entitled “Not Gonna Take it” and “Balloons” for YAZ Tablets submitted by Bayer HealthCare Pharmaceuticals, Inc. under cover of separate Forms.  The TV Ads are misleading because they broaden the drug’s indication, overstate the efficacy of YAZ, and minimize serious risks associated with the use of the drug.  Thus, the TV Ads misbrand the drug in violation of the Federal Food, Drug, and Cosmetic Act (the Act), and FDA’s implementing regulations.  These violations are concerning from a public health perspective because they encourage use of YAZ in circumstances other than those in which the drug has been approved, over-promise the benefits and minimize the risks associated with YAZ.”

The warning letter proceeds to state:

“Additionally, there are numerous warnings associated with the use of YAZ including, but not limited to, venous and arterial thrombotic and thromboembolic events (such as myocardial infraction, thromboembolism, stroke), hepatic neoplasia, gallbladder disease, and hypertension.  Moreover, YAZ has additional risks because it contains the progestin, drospirenone.  Drospirenone has antimineralocorticoid properties which can lead to hyperkalemia in high risk patients, which may result in potentially serious heart and health problems.  Women taking YAZ must be concerned about the drug interactions that could increase potassium, in addition to the drug interactions common to all combination oral contraceptives.”

To read the complete warning letter from the Department Of Health & Human Services, click here. 

What Is Yaz | October 2012 Yasmin News Update

Yaz is a birth control pill or oral contraceptive that contains the synthetic female hormone, progesterone called “drospirenone”.

Drospirenone, is a dangerous drug that causes many adverse effects including, DVT (deep vein thrombosis) and blood clots which in turn can cause heart attack, stroke, pulmonary embolisms and even death.

Birth control pills containing drospirenone include:

Yaz, Yasmin, BeYaz, Ocella, Yasminelle, Zarah and Angeliq

Bayer AG, the manufacturer of yaz and yasmin announced settlements totaling over $400,000 U.S. dollars as of August 2012.  There have been at least 1,900 cases resolved claiming the birth control pills caused heart attacks and/or strokes.  Bayer AG, paid out an average of $212,000 U.S. dollars per case.

Birth control pills containing drospirenone are required to include the following information:

A summary of previously released results of the FDA funded study regarding the blood clot risk, and that some epidemiologic studies show as high as a threefold increased risk for blood clots for birth control pills containing drospirenone.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

Yaz Injury Claims

Were you harmed while taking, Yaz, Yasmin, Ocella or Beyaz

Yaz, Yasmin, Beyaz and Ocella are dangerous drugs used for the purpose of preventing pregnancy.  They contain a drug called “Drospirenone”.  According to the FDA women using birth control pills containing progestogen hormones drospirenone, desogestrel or gestodene are 75 percent more likely to develop blood clots compared to those who use “older-generation” pills.

Drospirenone has been linked to many serious adverse events, including, but not limited to:  Chest pain, pain in the arms or shoulders, nausea, swelling of the hands and ankles, breast lumps, depression, wheezing and migraine headaches – among other symptoms.

It has been noted that women who are otherwise completely healthy, have experienced adverse events while taking Yaz, Yasmin, Ocella or Beyaz.

Steve Maher of the Maher Law Firm is an appointed Yaz MDL (Multi-District Litigation) Lawyer.  He does not represent the drug companies, he does not represent the insurance companies, he represents you.

You have the right to trust your medication is safe.  Tragically, this is not always the case.  Well versed in the product liability laws that protect consumers, our Yaz Attorneys have handled countless lawsuits involving harmful pharmaceuticals.  If you or a loved one have experienced side effects as a result of Yaz, Yasmin, Ocella or Beyaz, contact our Yaz Lawyers today.

 

Yaz and Yazmin (Yasmin)

Yaz and Yazmin (Yasmin) are oral contraceptives (birth control pills) manufactured by Bayer Healthcare Pharmaceutical

Yasmin and Yaz are oral contraceptives (birth control pills) manufactured for the prevention of pregnancy.  Yasmin was approved by the FDA (Food and Drug Administration) in 2001, Yaz was approved by the FDA in 2006.  Yaz and Yasmin prevent pregnancy by combining estrogen and a synthetic progestin known as “drospirenone”.

Drospirenone is a dangerous drug.  According to the FDA birth control pills containing drospirenone may be associated with a significantly higher risk of blood clots or DVT (Deep Vein Thrombosis) than birth control pills that do not contain drospirenone.  Since blood clots move through the body, there may be a threefold increased risk for heart attack, stroke, pulmonary embolism and even death due to DVT.

Women who are otherwise completely healthy, have experienced injuries and side effects after taking Yaz, Yasmin or Ocella.  In fact, Yasmin and Yaz have been linked to fifty deaths and hundreds of injuries.

Yaz and Yasmin lawsuit settlements have reached $402 million, Bayer AG pays out an average of $212 thousand per Yaz and Yasmin case, and has put aside a reserve of $610.5 million to settle Yaz and Yasmin cases.

Steve Maher – an experienced MDL attorney represents women who have been harmed by Yaz, Yasmin and Ocella.  Steve does not represent drug manufacturers or insurance companies, Steve represents you and your loved ones.  If you or a loved one has suffered injury or even death as a result of Yaz, Yasmin or Ocella use, contact The Maher Law Firm for a free case evaluation.

What We Now Know About Yaz, Yasmin and Ocella

Once Upon A Time………Yaz, Yasmin and Ocella were thought to be “different” forms of birth control that would helped offer some relief for those suffering from  PMDD (Premenstrual Dysphoric Disorder)

We now know that Yaz, Yasmin and Ocella birth control pills have a 74% increased risk for blood clots or venous thromboembolism, due to the synthetic progestin hormone known as Drospirenone.  Blood clots can break loose from the vein, move through the body and into the lungs, causing a pulmonary embolism which can result in death.

Each Yaz, Yasmin and Ocella birth control pill contains 3mg of Drospirenone.

As of April 2012, the FDA (Food and Drug Administration) required new labeling for birth control pills containing drospirenone that include the following information:

    • A summary of the previously released results of the FDA funded study regarding the blood clot risk.
      -AND-
    • That some epidemiologic studies show as high as a threefold increased risk for blood clots for birth control pills containing drospirenone.

Drospirenone also suppresses the secretion of the hormones that regulate the body’s water and electrolytes, which may cause higher potassium levels.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

FDA Warns Oral Contraceptives – Yaz, Yasmin – Have High Risk Of Blood Clots

Oral contraceptives that contain drospirenone have a threefold increase for risk of blood clots

The FDA (Food and Drug Administration) “has concluded that drospirenone containing birth control pills may be associated with a higher risk for blood clots than other progestin containing pills.”

Nine oral contraceptives containing 3mg of drospirenone and either 0.02 or 0.03 mg of ethinyl estradiol, will now note the risk of blood clots on their labels.  The oral contraceptives include:  Yaz, Yasmin, Ocella, Zarah, Beyaz, Gianvi, Syeda, Loryna, Safyral.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

FDA Will Soon Decide Fate of Bayer’s Risky Birth Control Pill, Yaz

It seems that the fate of Bayer’s new-generation birth control pill, Yaz, is in the hand of the U.S. Food and Drug Administration, as the regulatory agency meets on December 8th in order to determine whether or not the drug should be allowed to stay on the market.

Based on the results of an agency-funded study of drospirenone-contanting contraceptives, Yaz and other similar products were found to carry a 1.5-fold increased risk for causing potentially lethal blood clots compared to older-genration hormonal contraceptives.

To date, almost 10,000 lawsuits have been filed against Bayer, citing that Yaz caused blood-clot related heart attacks, strokes and even death. In fact, more than 190 women have died as a result of taking the drug.

Given the overwhelming evidence in support of the fact that blood clot events are far more likely to occur from pills containing drospirenone than from those containing levonorgestrel, an older progestin ingredient, the FDA will have to determine whether or not these products should remain on the market. This is a complex issue for the pharmaceutical industry, as drug makers contend that patients will still demand additional options, despite the proven risks associated with using a particular finished drug product. Moreover, the sense of urgency surrounding the issue continues to grow due to the fact that Yaz has gone off-patent, allowing for increased competition from generic products like Ocella, Safyral, Syeda and Zarah.

One thing remains clear, blood clots are extremely dangerous and unpredictable, which is why the FDA’s December 8th meeting is of the utmost importance.